These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 38732102)

  • 1. Structure-Function Analysis of the Essential
    Padayachee T; Lamb DC; Nelson DR; Syed K
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acetylene containing cyclo(L-Tyr-L-Tyr)-analogs as mechanism-based inhibitors of CYP121A1 from Mycobacterium tuberculosis.
    Ortega Ugalde S; Wallraven K; Speer A; Bitter W; Grossmann TN; Commandeur JNM
    Biochem Pharmacol; 2020 Jul; 177():113938. PubMed ID: 32224137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and evaluation against Mycobacterium tuberculosis of azole piperazine derivatives as dicyclotyrosine (cYY) mimics.
    El-Wahab HAAA; Accietto M; Marino LB; McLean KJ; Levy CW; Abdel-Rahman HM; El-Gendy MA; Munro AW; Aboraia AS; Simons C
    Bioorg Med Chem; 2018 Jan; 26(1):161-176. PubMed ID: 29183661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological evaluation of novel cYY analogues targeting Mycobacterium tuberculosis CYP121A1.
    Kishk SM; McLean KJ; Sood S; Helal MA; Gomaa MS; Salama I; Mostafa SM; de Carvalho LPS; Munro AW; Simons C
    Bioorg Med Chem; 2019 Apr; 27(8):1546-1561. PubMed ID: 30837169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Aryl Substituted Pyrazoles as Small Molecule Inhibitors of Cytochrome P450 CYP121A1: Synthesis and Antimycobacterial Evaluation.
    Taban IM; Elshihawy HEAE; Torun B; Zucchini B; Williamson CJ; Altuwairigi D; Ngu AST; McLean KJ; Levy CW; Sood S; Marino LB; Munro AW; de Carvalho LPS; Simons C
    J Med Chem; 2017 Dec; 60(24):10257-10267. PubMed ID: 29185746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substrate and reaction specificity of Mycobacterium tuberculosis cytochrome P450 CYP121: insights from biochemical studies and crystal structures.
    Fonvielle M; Le Du MH; Lequin O; Lecoq A; Jacquet M; Thai R; Dubois S; Grach G; Gondry M; Belin P
    J Biol Chem; 2013 Jun; 288(24):17347-59. PubMed ID: 23620594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural Characterization and Ligand/Inhibitor Identification Provide Functional Insights into the Mycobacterium tuberculosis Cytochrome P450 CYP126A1.
    Chenge JT; Duyet LV; Swami S; McLean KJ; Kavanagh ME; Coyne AG; Rigby SE; Cheesman MR; Girvan HM; Levy CW; Rupp B; von Kries JP; Abell C; Leys D; Munro AW
    J Biol Chem; 2017 Jan; 292(4):1310-1329. PubMed ID: 27932461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural biology and biochemistry of cytochrome P450 systems in Mycobacterium tuberculosis.
    McLean KJ; Munro AW
    Drug Metab Rev; 2008; 40(3):427-46. PubMed ID: 18642141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surface hydrophobics mediate functional dimerization of CYP121A1 of Mycobacterium tuberculosis.
    Kumar A; Campomizzi CS; Jay N; Ferguson S; Scheffler EJ; Lioi J; Tu C; Qu J; Simons C; Estrada DF
    Sci Rep; 2021 Jan; 11(1):394. PubMed ID: 33431984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Structure of Mycobacterium tuberculosis CYP125: molecular basis for cholesterol binding in a P450 needed for host infection.
    McLean KJ; Lafite P; Levy C; Cheesman MR; Mast N; Pikuleva IA; Leys D; Munro AW
    J Biol Chem; 2009 Dec; 284(51):35524-33. PubMed ID: 19846552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structure of the Mycobacterium tuberculosis P450 CYP121-fluconazole complex reveals new azole drug-P450 binding mode.
    Seward HE; Roujeinikova A; McLean KJ; Munro AW; Leys D
    J Biol Chem; 2006 Dec; 281(51):39437-43. PubMed ID: 17028183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential drug targets in the Mycobacterium tuberculosis cytochrome P450 system.
    Ortiz de Montellano PR
    J Inorg Biochem; 2018 Mar; 180():235-245. PubMed ID: 29352597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fragment Profiling Approach to Inhibitors of the Orphan M. tuberculosis P450 CYP144A1.
    Kavanagh ME; Chenge J; Zoufir A; McLean KJ; Coyne AG; Bender A; Munro AW; Abell C
    Biochemistry; 2017 Mar; 56(11):1559-1572. PubMed ID: 28169518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active Site Aromatic Residues Play a Dual Role in the Substrate Interaction and Protein Structure in Functional Dimers of CYP121A1 of
    Campomizzi CS; Kumar A; Uttamrao PP; Stallone JJ; Ghanatios GE; Rathinavelan T; Estrada DF
    ACS Infect Dis; 2023 Apr; 9(4):827-839. PubMed ID: 36976833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure, function and drug targeting in Mycobacterium tuberculosis cytochrome P450 systems.
    McLean KJ; Dunford AJ; Neeli R; Driscoll MD; Munro AW
    Arch Biochem Biophys; 2007 Aug; 464(2):228-40. PubMed ID: 17482138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of steroid and lipid binding cytochrome P450s from Mycobacterium marinum and Mycobacterium tuberculosis.
    Child SA; Ghith A; Bruning JB; Bell SG
    J Inorg Biochem; 2020 Aug; 209():111116. PubMed ID: 32473484
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Campomizzi CS; Ghanatios GE; Estrada DF
    J Biol Chem; 2021 Nov; 297(5):101287. PubMed ID: 34634307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of active site structure in CYP121. A cytochrome P450 essential for viability of Mycobacterium tuberculosis H37Rv.
    McLean KJ; Carroll P; Lewis DG; Dunford AJ; Seward HE; Neeli R; Cheesman MR; Marsollier L; Douglas P; Smith WE; Rosenkrands I; Cole ST; Leys D; Parish T; Munro AW
    J Biol Chem; 2008 Nov; 283(48):33406-16. PubMed ID: 18818197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structure of cytochrome P450 14alpha -sterol demethylase (CYP51) from Mycobacterium tuberculosis in complex with azole inhibitors.
    Podust LM; Poulos TL; Waterman MR
    Proc Natl Acad Sci U S A; 2001 Mar; 98(6):3068-73. PubMed ID: 11248033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytochromes P450: novel drug targets in the war against multidrug-resistant Mycobacterium tuberculosis.
    Munro AW; McLean KJ; Marshall KR; Warman AJ; Lewis G; Roitel O; Sutcliffe MJ; Kemp CA; Modi S; Scrutton NS; Leys D
    Biochem Soc Trans; 2003 Jun; 31(Pt 3):625-30. PubMed ID: 12773169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.